Why the study?
Ischemic cardio-cerebrovascular disease and depression cause high disability burdens and share common risk factors and mechanisms, but treatment breakthroughs remain lacking.
Design
Review
Authors
Loading...
Antioxidants should not yet change practice for this comorbidity; leaves open confirmatory trials of oxidative-stress targeting.
Key points are not available for this paper at this time.
Lin et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: